PR domain peptides

{
  "publication_number": "US6069231A",
  "country": "US",
  "kind": "A",
  "title": "PR domain peptides",
  "abstract": "The present invention provides PR domain peptides, which are about 100 to about 120 amino acids in length and contain three highly conserved sequences of about 10 to about 12 amino acids, separated by less conserved sequences of about 20 to about 35 amino acids.",
  "claims": [
    "1. A substantially purified PR domain peptide, comprising an amino acid sequence selected from the group consisting of amino acid positions 50 to 61 of RIZ (SEQ ID NO: 99), amino acid positions 88 to 99 of RIZ (SEQ ID NO: 99), amino acid positions 134 to 144 of RIZ (SEQ ID NO: 99), amino acid positions 71 to 82 of PRDI-BF1 (SEQ ID NO: 98), amino acid positions 71 to 82 of EVI-1 (SEQ ID NO: 100), amino acid positions 29 to 40 of egl-43 (SEQ ID NO: 101), amino acid positions 112 to 123 of PRDI-BF1(SEQ ID NO: 98), amino acid positions 108 to 119 of EVI-1 (SEQ ID NO: 100), amino acid positions 66 to 77 of egl-43 (SEQ ID NO: 101), amino acid positions 158 to 167 of PRDI-BF1 (SEQ ID NO: 98), amino acid positions 154 to 164 of EVI-1 (SEQ ID NO: 100), amino acid positions 108 to 117 of egl-43 (SEQ ID NO: 101) and amino acid positions 36 to 151 of SEQ ID NO: 2.",
    "2. The PR domain peptide of claim 1, wherein said amino acid sequence is amino acid positions 50 to 61 of RIZ (SEQ ID NO: 99).",
    "3. The PR domain peptide of claim 1, wherein said amino acid sequence is amino acid positions 88 to 99 of RIZ (SEQ ID NO: 99).",
    "4. The PR domain peptide of claim 1, wherein said amino acid sequence is amino acid positions 134 to 144 of RIZ (SEQ ID NO: 99).",
    "5. The PR domain peptide of claim 1, wherein said amino acid sequence is amino acid positions 71 to 82 of PRDI-BF1 (SEQ ID NO: 98).",
    "6. The PR domain peptide of claim 1, wherein said amino acid sequence is amino acid positions 71 to 82 of EVI-1 (SEQ ID NO: 100).",
    "7. The PR domain peptide of claim 1, wherein said amino acid sequence is amino acid positions 29 to 40 of egl-43 (SEQ ID NO: 101).",
    "8. The PR domain peptide of claim 1, wherein said amino acid sequence is amino acid positions 112 to 123 of PRDI-BF1(SEQ ID NO: 98).",
    "9. The PR domain peptide of claim 1, wherein said amino acid sequence is amino acid positions 108 to 119 of EVI-1 (SEQ ID NO: 100).",
    "10. The PR domain peptide of claim 1, wherein said amino acid sequence is amino acid positions 66 to 77 of egl-43 (SEQ ID NO: 101).",
    "11. The PR domain peptide of claim 1, wherein said amino acid sequence is amino acid positions 158 to 167 of PRDI-BF1 (SEQ ID NO: 98).",
    "12. The PR domain peptide of claim 1, wherein said amino acid sequence is amino acid positions 154 to 164 of EVI-1 (SEQ ID NO: 100).",
    "13. The PR domain peptide of claim 1, wherein said amino acid sequence is amino acid positions 108 to 117 of egl-43 (SEQ ID NO: 101).",
    "14. The PR domain peptide of claim 1, wherein said amino acid sequence is amino acid positions 36 to 151 of SEQ ID NO: 2.",
    "15. The PR domain peptide of claim 1, wherein said amino acid sequence is SEQ ID NO: 98.",
    "16. The PR domain peptide of claim 1, wherein said amino acid sequence is SEQ ID NO: 99.",
    "17. The PR domain peptide of claim 1, wherein said amino acid sequence is SEQ ID NO: 100.",
    "18. The PR domain peptide of claim 1, wherein said amino acid sequence is SEQ ID NO: 101."
  ],
  "cpc": [
    "C07K 14/4702",
    "A61K 38/00",
    "A61P 35/00"
  ],
  "assignees": [
    "JOLLA CANCER RES FOUND"
  ],
  "filing_date": "1995-08-18",
  "publication_date": "2000-05-30",
  "grant_date": "2000-05-30",
  "priority_date": "1994-08-18",
  "application_number": "US-51685995-A",
  "family_id": "26967494"
}